Caribou Biosciences, Inc. Cash Flow Statement

Cash Flow Statement Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -23.43M-34.31M-66.92M-99.42M-102.07M-149.10M
Depreciation and Depletion 0.00M0.90M0.00M
Share-based Compensation 1.23M1.00M3.45M11.72M13.75M16.71M
Gains from Investment Securities 1.81M4.52M6.76M26.25M0.17M
Non-cash Items 6.93M50.09M
Cash from Operations -32.01M-33.22M-32.52M-90.97M-93.29M-138.20M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles -0.05M0.80M4.42M4.73M
Depreciation & Amortization (CF) 0.75M0.90M0.98M1.62M3.52M3.93M
Change in Working Capital
Change in Receivables 0.87M0.54M1.80M-3.27M0.07M-0.46M
Change in Account Payables 1.18M0.04M1.14M-2.72M1.82M-0.35M
Change in Accured Expenses 0.70M2.29M4.28M1.95M5.74M2.13M
Other Working Capital Changes -7.11M-0.60M29.64M-4.84M-16.94M3.94M
Investing Activities
Capital Expenditures 0.89M0.32M2.12M6.45M11.61M4.88M
Sales of Property, Plant and Equipment 0.01M0.01M
Change in Acquisitions & Divestments 252.87M338.19M397.49M
Cash from Investing Activities 27.23M6.36M-176.40M-93.25M-68.18M86.61M
Financing Activities
Cash from Financing Activities 0.17M1.74M433.43M2.13M154.30M16.72M
Additional items
Change in Cash -4.60M-25.12M224.51M-182.08M-7.18M-34.87M
Free Cash Flow -32.89M-33.53M-34.64M-97.42M-104.90M-143.08M
Net Cash Flow -4.60M-25.12M224.51M-182.08M-7.18M-34.87M